Four pharma firms face US price-fixing charge

US lawmakers turn the heat on Dr Reddy's, Glenmark, Sun Pharma and Emcure

As many as four Indian drugmakers are facing allegations of a huge price-fixing conspiracy in the US aimed at keeping prices of generic drugs artificially high. The companies are Dr Reddy’s Laboratories (DRL), Glenmark Pharmaceuticals, Sun Pharmaceutical Industries, and Emcure Pharmaceuticals. 

Two top executives — Pune-based Emcure’s Managing Director Satish Mehta and US-based Mylan NV’s Executive Director Rajiv Malik — were accused on Tuesday of being part of the conspiracy. More executives in the industry are under the scanner.

“Given the direct involvement of executives in this case and the evidence we had implicating them, we felt as a group